Ergoteles’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-35,629
| Closed | -$1.28M | – | 1106 |
|
|
2023
Q1 | $1.28M | Sell |
35,629
-391
| -1% | -$14.1K | 0.05% | 406 |
|
|
2022
Q4 | $1.61M | Buy |
+36,020
| New | +$1.61M | 0.06% | 328 |
|
|
2022
Q2 | – | Sell |
-11,702
| Closed | -$399K | – | 1680 |
|
|
2022
Q1 | $399K | Sell |
11,702
-4,459
| -28% | -$152K | 0.02% | 750 |
|
|
2021
Q4 | $624K | Buy |
+16,161
| New | +$624K | 0.02% | 561 |
|
|
2021
Q1 | – | Sell |
-31,500
| Closed | -$552K | – | 826 |
|
|
2020
Q4 | $552K | Buy |
+31,500
| New | +$552K | 0.02% | 432 |
|